Okeoghene Marcel Edafetanure-Ibeh

Okeoghene Marcel Edafetanure-Ibeh

Auto-generated profile, based on publicly available information

Okeoghene Marcel Edafetanure-Ibeh

Department of Environmental and Occupational Health, Texas A&M School of Public Health, 212 Adriance Lab Rd, College Station, TX 77843, United States of America

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 July 2024 in Acta Elit Salutis
Verified
Journal Article
Open access
SESeyi Samson Enitan
Seyi Samson Enitan
KAKirellos Said Abbas
Kirellos Said Abbas
RERawan Raad Hassan Elrufai
Rawan Raad Hassan Elrufai
SUSolomon Umukoro
Solomon Umukoro
CTCausette Laura Metago Tsague
Causette Laura Metago Tsague
COChisom Blossom Onyeji
Chisom Blossom Onyeji
Dengue Fever remains a pressing public health concern in the Global South, including in Africa, where limited resources, inadequate surveillance, weak health systems, climate change, and urbanization exacerbate the threat. This review study focuses on strategies to strengthen preparedness, capacity building efforts on surveillance, vector control, health system strengthening, community engagement, and research. Investing in training programs, research initiatives, and regional collaboration is vital. Advocacy for increased political commitment and resource allocation is necessary to drive policy support. African nations are actively contributing to global Dengue control efforts, showcasing resilience amidst adversity. There are promising prospects for improvement. Enhanced surveillance, capacity building, community engagement, research, and regional collaboration are identified as crucial strategies. Strengthening surveillance systems can provide accurate data for targeted interventions, while investing in healthcare infrastructure and training can improve diagnosis and treatment capabilities. Community engagement and education efforts can promote preventive behaviours, and research initiatives drive progress in Dengue prevention and control. Additionally, regional collaboration fosters knowledge exchange and resource sharing. By addressing these challenges and capitalizing on emerging opportunities, Africa can further strengthen its contribution to global Dengue control efforts. Through sustained investment, collaboration, and innovation, Africa has the potential to mitigate Dengue's impact and inspire similar efforts worldwide. Advocacy for increased political commitment and resource allocation is essential to drive policy support. By prioritizing Dengue control and implementing sustainable interventions tailored to local contexts, Africa can enhance public health resilience and contribute significantly to the global fight against Dengue.

29 June 2025 in Global South Health Horizons
Verified
Journal Article
Open access
PDF file
SESeyi Samson Enitan
Seyi Samson Enitan
EAEsther Adejumo
Esther Adejumo
OOOsareniro Osakue
Osareniro Osakue
SESamuel EKE
Samuel EKE
RARichard Akele
Richard Akele
CEComfort Enitan
Comfort Enitan
Introduction: The integration of genomics and proteomics, two cornerstone omics technologies, has transformed our understanding of biological systems, enabling deeper insights into disease mechanisms, biomarker discovery, and the development of personalised medicine. While genomics uncovers genetic blueprints, proteomics reveals functional protein expressions, making their combined use essential for a holistic view of biological processes. This narrative review explores the current state, advantages, challenges, and prospects of integrating genomics and proteomics in biological research, particularly in the context of translational medicine and global health applications. Methods: A systematic literature search was conducted across four databases—PubMed, Scopus, Web of Science, and Google Scholar, for English-language peer-reviewed articles published between January 2015 and May 2025. A PRISMA-based approach guided article screening and selection. Inclusion criteria focused on studies addressing multi-omics integration, relevant technologies, clinical applications, and associated ethical concerns. The findings were synthesised using thematic analysis. Synthesis: The review highlights the growing synergy between genomics and proteomics in enhancing disease diagnosis, drug discovery, and precision medicine. Advances in next-generation sequencing and mass spectrometry, coupled with computational tools such as MOFA+ and AlphaFold, have improved data integration. However, challenges persist, including high data complexity, computational demands, ethical/legal concerns, and limited access in low-resource settings. Conclusion: Integrated omics approaches hold immense potential to revolutionise healthcare and biological discovery. Addressing current barriers and fostering global collaboration, particularly in underrepresented regions, are critical to realising the full benefits of genomics and proteomics integration.

28 December 2024 in Avicenna Journal of Clinical Microbiology and Infection
Verified
Journal Article
Open access
PDF file
SESeyi Samson Enitan
Seyi Samson Enitan
RARichard Yomi Akele
Richard Yomi Akele
AOAdesuyi Ayodeji Omoare
Adesuyi Ayodeji Omoare
BDBanenat Dogonyaro
Banenat Dogonyaro
MIMichael Unata Iduh
Michael Unata Iduh
TATemitayo Oluwatomisin Ajayi
Temitayo Oluwatomisin Ajayi
Mpox, declared a Public Health Emergency of International Concern by the World Health Organization (WHO), poses a growing global threat. The resurgence, driven by the highly transmissible and severe clade Ib strain from the Democratic Republic of the Congo, raises concerns about a potential pandemic. This narrative review aims to identify actionable strategies to mitigate the current Mpox outbreak by leveraging lessons from past health crises, particularly COVID-19, and to highlight future research priorities essential for global preparedness. A comprehensive literature review from 2018 to 2024 was conducted using Google Scholar, Scopus, and PubMed databases, focusing on Mpox transmission, vaccine efficacy, antiviral treatments, and public health responses. Our findings revealed that the resurgence of Mpox is fueled by viral evolution, ecological changes, and inadequate surveillance, exacerbated by inequitable healthcare access and insufficient public health infrastructure. While existing vaccines, such as Jynneos and ACAM2000, offer protection, their long-term efficacy and safety across diverse populations require further study. Antiviral treatments, including tecovirimat and brincidofovir, show promise but lack optimized care protocols and face challenges such as emerging resistance. Lessons from the COVID-19 response underscore the importance of enhancing global surveillance systems, strengthening healthcare infrastructure, ensuring equitable vaccine distribution, and fostering community engagement. Effective Mpox management also requires standardized treatment guidelines and the integration of genomic monitoring to track viral evolution and drug resistance. Urgent international collaboration is needed to avert a potential Mpox pandemic. Priorities include advancing research on long-term vaccine efficacy, optimizing antiviral therapies, and improving care for severe cases. Actionable recommendations include robust policies, sustainable funding, and global collaboration to strengthen pandemic preparedness and mitigate Mpox’s impact.

14 October 2024 in Afro-Egyptian Journal of Infectious and Endemic Diseases
Verified
Journal Article
Open access
PDF file
FIFavour A Idowu
Favour A Idowu
SESeyi Samson Enitan
Seyi Samson Enitan
MIMichael U Iduh
Michael U Iduh
SMStephen O Makanjuola
Stephen O Makanjuola
RARichard Y Akele
Richard Y Akele
EEEffiong J Effiong
Effiong J Effiong
Background and study aim: In Nigeria, there is paucity of information on the epidemiology of infections due to Chikungunya virus (CHIKV) especially among patients with febrile illness. Cases of febrile illness are usually associated with malaria and typhoid fever without considering the possibility of viral aetiology. The aim of the study was to determine the prevalence and associated risk factors of CHIKV infections among febrile illness presumptively diagnosed of malaria in Ogun State, Nigeria. Patients and Methods: A total of 165 patients (94 females and 71 males) were recruited for the study. The presence of malarial parasite was determined by microscopic examination of blood films. Sera were tested for presence of CHIKV immunoglobin (Ig) IgM and IgG antibodies using CHIKV rapid diagnostic test kit. Results: Out of the 165 patients screened, 102 (61.8%) were positive for malarial parasite, 18 (10.9%), 5 (3.0%) and 4 (2.4%) were positive for the presence of CHIKV IgM Ab only, CHIKV IgG Ab only, and both, respectively. A statistically significant association was observed between CHIKV IgM antibody positivity and malaria. Participants who tested positive for CHIKV IgG antibody only were all negative for malaria. Meanwhile, participants positive for both CHIKV IgM and IgG antibodies did not test positive for malaria. Lack of knowledge of CHIKV, presence of mosquitos in the environment, presence of stagnant water sources around, lack of routine medical check-ups and self-medication practices are some of the risk factors identified in this study. Conclusion: The findings underscore the importance of considering CHIKV infection alongside malaria in febrile patients, particularly in malaria-endemic regions.

26 August 2026 in Computational Biology and Chemistry
Verified
Journal Article
Closed access
LOLinda Osaghale
Linda Osaghale
ABAbeni Beshiru
Abeni Beshiru
OEOkeoghene Marcel Edafetanure-Ibeh
Okeoghene Marcel Edafetanure-Ibeh
SASamuel Oluwasegun Ajoseh
Samuel Oluwasegun Ajoseh
ADAryaan Paul Duggal
Aryaan Paul Duggal

6 July 2025 in Jordan Medical Journal
Verified
Journal Article
Closed access
MDMichael Dada
Michael Dada
SESeyi Enitan
Seyi Enitan
RARichard Akele
Richard Akele
OEOkeoghene Edafetanure-Ibeh
Okeoghene Edafetanure-Ibeh
AOAdesuyi Ayodeji Omoare
Adesuyi Ayodeji Omoare
FEFaith Edafetanure-Ibeh
Faith Edafetanure-Ibeh
Background: Mpox (formerly monkeypox) has emerged as a critical public health issue worldwide, characterized by notable differences in acquisition and disease severity between Africa and the Americas. Understanding the interplay of behavioral, virologic, and immunologic factors is essential to addressing these disparities. Aim: This review examines the behavioral, virologic, and immunologic determinants influencing Mpox acquisition and severity, with a focus on regional variations in Africa and the Americas. Methodology: A narrative review was conducted using peer-reviewed articles, public health reports, and official guidelines published between 2019 and 2024. Key sources were identified via databases including PubMed, Scopus, and Google Scholar. Analysis centered on behavioral risk factors (e.g., sexual networks, wildlife exposure), virologic attributes (e.g., viral clades), and immunologic influences (e.g., vaccination status). Results: The findings reveal distinct regional differences in Mpox transmission dynamics and outcomes. In Africa, zoonotic transmission is prominent, compounded by poor hygiene and under-resourced healthcare systems. In the Americas, outbreaks are driven predominantly by human-to-human transmission within sexual networks, particularly among men who have sex with men (MSM), and international travel. Virologically, the Central African clade demonstrates greater virulence than the West African clade, which has predominated recent global outbreaks. Immunologically, limited smallpox vaccination coverage in younger African populations has increased vulnerability, while partial cross-protection from smallpox vaccines in the Americas has mitigated disease severity to some extent. Conclusion: Effective Mpox control necessitates region-specific public health strategies. Enhanced vaccination programs, improved healthcare infrastructure, and tailored interventions addressing behavioral and virologic drivers are critical. Global collaboration is imperative to mitigate Mpox's spread and burden while addressing socio-economic and epidemiological disparities.